The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Know Your Labs

Know Your Labs

February 1, 2009 • By Peter H. Schur, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

In my opinion, the indications for ordering an anti-Ro/SSA and anti-La/SSB antibody tests are as follows:

You Might Also Like
  • Know Your Labs, Part 2
  • New Study Reveals Limitations in ANA Test Kits for Lupus
  • Insurer Updates
Explore This Issue
February 2009
Also By This Author
  • Laboratory Testing for Diagnosis, Management of Patients with Rheumatic Disease
  • Women with SLE who are pregnant or may become pregnant in the future;
  • Women who have a history of giving birth to a child with heart block or myocarditis;
  • Patients with a history of unexplained photosensitive skin eruptions;
  • Patients strongly suspected of having SLE but who have a negative ANA test; or
  • Patients with symptoms of xerostomia, keratoconjunctivitis sicca, and/or salivary and lacrimal gland enlargement.

Antiribosomal P Protein Antibodies

Anti-ribosomal P protein antibodies have been detected in 10% to 20% of patients with SLE in the United States and 40% to 50% of Asian patients with SLE, but rarely in other rheumatic diseases.30 Anti-ribosomal P protein antibodies may be highly specific for lupus-associated psychosis, although not all studies have confirmed this. Depression and renal and liver involvement in patients with lupus have also been associated with anti-ribosomal P protein antibodies in some small studies.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Because of the low sensitivity and poor clinical correlation, many investigators—including myself—see little clinical usefulness in this test.

Anti-Centromere Antibodies

Anti-centromere antibodies (ACAs) are found almost exclusively in patients with limited cutaneous systemic sclerosis (lcSSc) especially in those with CREST.31 ACAs have been observed in 57% of patients with CREST but have also been seen in patients with other conditions, including in some patients with Raynaud’s phenomenon alone. ACAs are typically detected by the characteristic IF pattern on Hep-2 cells.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Anti–Scl-70 (topoisomerase-1) Antibodies

Approximately 15% to 20% of patients with scleroderma have antibodies to a 70kd protein (topoisomerase-1), subsequently named Scl-70.31 The usual method for detection is by ELISA. The presence of these antibodies appears to increase the risk for pulmonary fibrosis among patients with scleroderma and is quite specific for the disease.

Summary

If one suspects SLE based on the history, physical examination, and complete blood count (e.g., leucopenia, thrombocytopenia), request an ANA test. If it is negative, it is highly unlikely that the patient has SLE, and the patient can be reassured. If the titer is <1:160, SLE is unlikely, and the patient can be reassured that SLE is unlikely, but the patient should be followed periodically. A titer of ≥1:160 increases the likelihood of SLE and related disorders. However, it is important to remember that 85% of individuals with a positive ANA do not have SLE. If the ANA is positive, one should also test for antibodies to dsDNA, Sm, RNP, Ro/SSA, and La/SSB. The presence of these antibodies greatly increases the likelihood that the patient has SLE and related disorders (see Table 2, p. 17), and the patient needs to be followed more closely. The detection of anti-centromere and anti–Scl-70 antibodies is very useful for the diagnosis of scleroderma. The detection of antibodies to Ro/SSA and La/SSB are also useful for the diagnosis of Sjögren’s syndrome.

Pages: 1 2 3 4 5 6 7 | Single Page

Filed Under: Conditions, Scleroderma, SLE (Lupus) Tagged With: connective tissue disease, Diagnosis, Systemic lupus erythematosus, TestingIssue: February 2009

You Might Also Like:
  • Know Your Labs, Part 2
  • New Study Reveals Limitations in ANA Test Kits for Lupus
  • Insurer Updates
  • Some Lupus Tests Yield False Results

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.